- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Recently Accepted Articles ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 402375, 7 pages
Endostatin/Collagen XVIII Is Increased in Cerebrospinal Fluid after Severe Traumatic Brain Injury
1Department of Neurosurgery, Shanghai Sixth People’s Hospital, Shanghai Jiaotong University, 600 Yishan Road,
Shanghai 200233, China
2Department of Neurology, Shanghai Sixth People’s Hospital, Shanghai Jiaotong University, Shanghai 200233, China
Received 20 April 2013; Revised 31 July 2013; Accepted 31 July 2013
Academic Editor: Eduardo Gonzalez-Toledo
Copyright © 2013 Hao Chen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- N. M. Pandya, N. S. Dhalla, and D. D. Santani, “Angiogenesis—a new target for future therapy,” Vascular Pharmacology, vol. 44, no. 5, pp. 265–274, 2006.
- M. K. Sköld, M. Risling, and S. Holmin, “Inhibition of vascular endothelial growth factor receptor 2 activity in experimental brain contusions aggravates injury outcome and leads to early increased neuronal and glial degeneration,” European Journal of Neuroscience, vol. 23, no. 1, pp. 21–34, 2006.
- R. Morgan, C. W. Kreipke, G. Roberts, M. Bagchi, and J. A. Rafols, “Neovascularization following traumatic brain injury: possible evidence for both angiogenesis and vasculogenesis,” Neurological Research, vol. 29, no. 4, pp. 375–381, 2007.
- S. Nag, J. L. Takahashi, and D. W. Kilty, “Role of vascular endothelial growth factor in blood-brain barrier breakdown and angiogenesis in brain trauma,” Journal of Neuropathology and Experimental Neurology, vol. 56, no. 8, pp. 912–921, 1997.
- S. Nag, M. R. Eskandarian, J. Davis, and J. H. Eubanks, “Differential expression of vascular endothelial growth factor-A (VEGF-A) and VEGF-B after brain injury,” Journal of Neuropathology and Experimental Neurology, vol. 61, no. 9, pp. 778–788, 2002.
- J. E. Italiano Jr., J. L. Richardson, S. Patel-Hett et al., “Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet α granules and differentially released,” Blood, vol. 111, no. 3, pp. 1227–1233, 2008.
- P. M. Shore, E. K. Jackson, S. R. Wisniewski et al., “Vascular endothelial growth factor is increased in cerebrospinal fluid after traumatic brain injury in infants and children,” Neurosurgery, vol. 54, no. 3, pp. 605–612, 2004.
- M. K. Sköld, C. von Gertten, A. C. Sandberg-Nordqvist, T. Mathiesen, and S. Holmin, “VEGF and VEGF receptor expression after experimental brain contusion in rat,” Journal of Neurotrauma, vol. 22, no. 3, pp. 353–367, 2005.
- D. Gong, S. Zhang, L. Liu et al., “Dynamic changes of vascular endothelial growth factor and angiopoietin-1 in association with circulating endothelial progenitor cells after severe traumatic brain injury,” Journal of Trauma-Injury, Infection and Critical Care, vol. 70, no. 6, pp. 1480–1484, 2011.
- C. A. Mueller, H. J. Schluesener, U. Fauser, S. Conrad, and J. M. Schwab, “Lesional expression of the endogenous angiogenesis inhibitor endostatin/collagen XVIII following traumatic brain injury (TBI),” Experimental Neurology, vol. 208, no. 2, pp. 228–237, 2007.
- Z. Y. Zhang, Z. Zhang, U. Fauser, M. Artelt, M. Burnet, and H. J. Schluesener, “Dexamethasone transiently attenuates up-regulation of endostatin/collagen XVIII following traumatic brain injury,” Neuroscience, vol. 147, no. 3, pp. 720–726, 2007.
- M. H. Deininger, R. Meyermann, and H. J. Schluesener, “Endostatin/collagen XVIII accumulates in patients with traumatic brain injury,” Journal of Neurotrauma, vol. 23, no. 7, pp. 1103–1110, 2006.
- The Brain Trauma Foundation, “Guidelines for the management of severe head injury. Introduction,” Journal of Neurotrauma, vol. 13, no. 11, pp. 643–645, 1996.
- G. M. Teasdale, L. E. L. Pettigrew, J. T. L. Wilson, G. Murray, and B. Jennett, “Analyzing outcome of treatment of severe head injury: a review and update on advancing the use of the Glasgow Outcome Scale,” Journal of Neurotrauma, vol. 15, no. 8, pp. 587–597, 1998.
- D. Wenzel, A. Schmidt, K. Reimann et al., “Endostatin, the proteolytic fragment of collagen XVIII, induces vasorelaxation,” Circulation Research, vol. 98, no. 9, pp. 1203–1211, 2006.
- L. Seppinen, R. Sormunen, Y. Soini, H. Elamaa, R. Heljasvaara, and T. Pihlajaniemi, “Lack of collagen XVIII accelerates cutaneous wound healing, while overexpression of its endostatin domain leads to delayed healing,” Matrix Biology, vol. 27, no. 6, pp. 535–546, 2008.
- W. Bloch, K. Huggel, T. Sasaki et al., “The angiogenesis inhibitor endostatin impairs blood vessel maturation during wound healing,” The FASEB Journal, vol. 14, no. 15, pp. 2373–2376, 2000.
- C. A. Mueller, S. Conrad, H. J. Schluesener, T. Pietsch, and J. M. Schwab, “Spinal cord injury-induced expression of the antiangiogenic endostatin/collagen XVIII in areas of vascular remodelling,” Journal of Neurosurgery, vol. 7, no. 2, pp. 205–214, 2007.
- R. Benezra and S. Rafii, “Endostatin's endpoints—deciphering the endostatin antiangiogenic pathway,” Cancer Cell, vol. 5, no. 3, pp. 205–206, 2004.
- Q. Tao, S. C. Spring, and B. I. Terman, “Comparison of the signaling mechanisms by which VEGF, H2O2, and phosphatase inhibitors activate endothelial cell ERK1/2 MAP-kinase,” Microvascular Research, vol. 69, no. 1-2, pp. 36–44, 2005.